Status:
COMPLETED
FST-100 in the Treatment of Acute Adenoviral Conjunctivitis
Lead Sponsor:
Shire
Conditions:
Acute Adenoviral Conjunctivitis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This randomized, double masked, multi-center study is being conducted to support the safety and efficacy of FST-100 for the treatment of acute adenoviral conjunctivitis.
Eligibility Criteria
Inclusion
- Have a clinical diagnosis of suspected acute adenoviral conjunctivitis in at least one eye.
Exclusion
- Have a known sensitivity to any of the components of FST-100 or FST-100 vehicle.
Key Trial Info
Start Date :
December 17 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 23 2014
Estimated Enrollment :
176 Patients enrolled
Trial Details
Trial ID
NCT01470664
Start Date
December 17 2012
End Date
May 23 2014
Last Update
June 25 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ora, Inc.
Andover, Massachusetts, United States, 01810
2
Ora, Inc.
Noida, India, 201301